Search clinical trials

Results for SEARCH ALL

Total 285128 results
Search term:


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 Last


#
NCTID/Status
Study
Last Changed

272151
NCT00113555
Completed
July 5, 2018

272152
NCT00113542
Completed
May 20, 2015

272153
NCT00113529
Completed
August 25, 2011

272154
NCT00113516
Completed
May 14, 2010

272155
NCT00113503
Terminated
Imuran Dosing in Crohn's Disease Study

Conditions: Crohn's Disease
October 4, 2017

272156
NCT00113490
Completed
April 3, 2013

272157
NCT00113477
Completed
June 30, 2011

272158
NCT00113464
Completed
June 30, 2017

272159
NCT00113451
Completed
Radial Artery Bypass Graft Study of Tromsø

Conditions: Coronary Arteriosclerosis; Myocardial Infarction
June 23, 2005

272160
NCT00113438
Completed
October 28, 2011

272161
NCT00113425
Completed
August 22, 2016

272162
NCT00113412
Unknown status
March 21, 2006



272165
NCT00113373
Completed
Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer

Conditions: Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer
May 3, 2018

272166
NCT00113360
Completed
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Conditions: Neuroendocrine Carcinoma; Islet Cell Carcinoma
August 1, 2012

272167
NCT00113347
Completed
February 23, 2012

272168
NCT00113334
Completed
July 14, 2014

272169
NCT00113321
Terminated
Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure

Conditions: Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia
August 1, 2012

272170
NCT00113308
Completed
March 13, 2017

272171
NCT00113295
Completed
March 20, 2014


272173
NCT00113269
Completed
August 9, 2011

272174
NCT00113256
Terminated
January 22, 2013

272175
NCT00113243
Unknown status
June 23, 2005

272176
NCT00113230
Completed
July 31, 2012

272177
NCT00113217
Completed
December 2, 2013

272178
NCT00113204
Completed
May 15, 2008

272179
NCT00113191
Completed
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Conditions: Nosocomial Infections; Sepsis; Staphylococcal Infections; Candidemia
July 26, 2012

272180
NCT00113178
Completed
February 23, 2011

272181
NCT00113165
Completed
December 2, 2016

272182
NCT00113152
Completed
Heart Disease in Sickle Cell Anemia

Conditions: Sickle Cell Anemia; Pulmonary Hypertension
June 30, 2017

272183
NCT00113139
Completed
July 11, 2014

272184
NCT00113126
Completed
November 28, 2006

272185
NCT00113113
Completed
January 22, 2013

272186
NCT00113100
Completed
Mechanisms of Skin Repair by Topical Estrogen

Conditions: Skin Wrinkling
May 20, 2015

272187
NCT00113087
Completed
September 16, 2010

272188
NCT00113074
Completed
Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers

Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension
January 7, 2013

272189
NCT00113061
Completed
Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults

Conditions: Cardiovascular Diseases; Heart Diseases; Obesity
July 28, 2016

272190
NCT00113048
Terminated
February 4, 2014


272192
NCT00113022
Terminated
Org 24448 to Treat Major Depression

Conditions: Depression
July 9, 2012

272193
NCT00113009
Completed
November 21, 2007

272194
NCT00112996
Completed
Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

Conditions: Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
April 7, 2014

272195
NCT00112983
Completed
May 29, 2013

272196
NCT00112957
Completed
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
March 15, 2018

272197
NCT00112931
Active, not recruiting
October 24, 2017


272199
NCT00112905
Terminated
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Conditions: Adenocarcinoma of the Bladder; Distal Urethral Cancer; Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter; Proximal Urethral Cancer; Recurrent Bladder Cancer; Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter; Recurrent Urethral Cancer; Regional Transitional Cell Cancer of the Renal Pelvis and Ureter; Squamous Cell Carcinoma of the Bladder; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder; Urethral Cancer Associated With Invasive Bladder Cancer
May 20, 2014

272200
NCT00112892
Completed
Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
January 10, 2014


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 Last




© 2018 ICH GCP